Duration of Reporter Gene Expression from Naked pDNA in the Mouse Lung following Direct Electroporation and Development of Wire Electrodes for Sheep Lung Electroporation Studies. (2004)

Pringle, I. A., Davies, L. A., McLachlan, G., Collie, D. D. S., Gill, D. R. & Hyde, S. C.

Molecular Therapy, 9, S56

Download   Back

Current non-viral vectors for lung gene transfer are limited by inefficient uptake, and low levels of expression in cells throughout the lung. The use of electroporation to enhance reporter gene expression from naked plasmid DNA (pDNA) in the mouse lung has been assessed. A direct electroporation model has been established, in which following delivery of pDNA and electroporation of the left lung, luciferase reporter gene expression has been enhanced by up to 500 fold compared to the non-electroporated right lung depending on the combination of plasmid, field strength (V/cm) and pulse length employed. Furthermore, following delivery of a GFP expressing plasmid, up to 5 % of the left lung cells were positive for GFP after electroporation. Now, the duration of Lux activity following electroporation of the mouse lung has been assessed. Female BALB/c mice were anaesthetised with isoflurane and received 100 µg pUbLux (human ubiquitin C promoter, Lux transgene) in 150 µl water. The left lungs of mice were exposed by performing a lateral thoracotomy. Electroporation of the left lung (8 pulses of 800V/cm, 2ms with a 1 sec interval) was carried out using the BTX ECMÆ830 Generator with 2-Needle electrodes with 5mm gap with the right lungs remaining non electroporated. Lux activity was measured at 2, 14 and 28 days post dosing. At day 2 post dosing, mean Lux activity in the left lungs of mice was 40 fold higher than the right lung (Mann-Whitney U: P=0.016). The Lux activity in the left lungs at day 28 post dosing was no different to the level at day 2 (P=0.512) and still significantly higher than the activity observed in the right lung (P=0.050). Therefore this study has established that direct electroporation of the mouse lung can result in high levels of Lux activity from naked pDNA and that this level persists for at least 28 days post dosing. In similar studies with the plasmid pCIKLux (CMV promoter, Lux transgene), electroporation resulted in far greater levels of expression at day 2 post dosing, but by day 14, the Lux activity had fallen to background levels. The safety and efficacy of lung electroporation has therefore been well established in the mouse lung. Further development of lung electroporation is now planned in the sheep lung, as a larger animal model will be more relevant for clinical development of this approach. A series of wire electrodes have been constructed from Teflon insulated stainless steel up to 80cm in length with a diameter of just 0.3mm. In an ex vivo mouse lung model, electroporation with these wires following pCIKLux intranasal delivery (100µg pDNA/150µl) resulted in equivalent 200 fold increases in Lux activity to commercially available needle electrodes. These wire electrodes will be placed within the sheep airways with a bronchoscope allowing for a range of electroporation studies to be carried out. These studies will determine if it the electric field can be efficiently and safely applied over a large area to allow electroporation to be used for improving gene transfer throughout the whole lung.

Home
News
Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Careers
Resources
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images

 

UK CFGTC

How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

Milestones

GL67A/pGM169

The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial

 

Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links

 

Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links

 

 

Publications

Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses

Lectures

 

Gene Therapy Seminars

Schedule

Directions & Venue